Clinical Trials List
2019-05-31 - 2026-12-31
Phase III
Recruiting3
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- SUNG-TSANG HSIEH Division of Neurology
- Jen Jen and I Su Division of Neurology
- YEN-HUNG LIN Division of General Internal Medicine
- HSUEH-WEN HSUEH Division of Neurology
- LI-KAI TSAI Division of Neurology
- Ming-Jen Lee Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 賴冠霖 Division of Neurology
- Kon-Ping Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張宏旭 Division of Neurology
- Hong-Chou Kuo Division of Neurology
- 呂榮國 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
160 participants
